Table 1.
Clinical Characteristics of SMILE Participants with Biomedical Data
| N* | Total** | %, (SD), (Range) | |
|---|---|---|---|
| Mean age (years) (SD) | 733 | 20.6 | (2.3) |
| Birth gender | 732 | ||
| Male | 589 | 80% | |
| Female | 143 | 20% | |
| Current gender | 727 | ||
| Male | 569 | 78% | |
| Female | 148 | 20% | |
| Transgender (M to F) | 10 | 1% | |
| Sexual orientation | 729 | ||
| Heterosexual | 198 | 27% | |
| Bisexual | 69 | 9% | |
| Homosexual | 395 | 54% | |
| Questioning/Unsure | 7 | 1% | |
| Declined to answer | 60 | 8% | |
| Race/Ethnicity | 701 | ||
| Non-Hispanic white | 42 | 6% | |
| Non-Hispanic black | 507 | 72% | |
| Hispanic | 123 | 18% | |
| Other | 29 | 4% | |
| Mode of HIV acquisition | 727 | ||
| Perinatal | 47 | 6% | |
| Heterosexual Contact | 38 | 5% | |
| Injection Drug Use (IDU) | 3 | 0.4% | |
| Male to Male Sexual (MSM) Contact | 455 | 63% | |
| MSM Contact and IDU | 12 | 2% | |
| Uncertain / Unknown | 126 | 17% | |
| Declined to answer | 46 | 6% | |
| Received medical care for HIV before | 730 | ||
| Yes | 173 | 24% | |
| No | 471 | 65% | |
| Declined to answer | 86 | 12% | |
| Received ART at most recent visit | 733 | ||
| Yes | 115 | 16% | |
| No | 618 | 84% | |
| Baseline viral load (copies /mL) | 733 | ||
| Mean (SD) | 152,217 | (743,971) | |
| Median (Range) | 23,234 | (5-107) | |
| Baseline CD4 cell count (cells/mL) | 733 | ||
| Mean (SD) | 463.2 | (251.9) | |
| Median (Range) | 422 | (2–1,530) | |
| Used ≥ 1 substance in past 6 months*** | 732 | ||
| Yes | 383 | 52% | |
| No | 349 | 48% | |
| Had sex with an anonymous partner in past 6 months | 732 | ||
| Yes | 91 | 12% | |
| No | 641 | 88% | |
| Engaged in transactional sex | 732 | ||
| Yes | 27 | 4% | |
| No | 705 | 96% | |
| Had ≥ 1 STI in past 6 months | 732 | ||
| Yes | 182 | 25% | |
| No | 550 | 75% | |
*
N = 733 SMILE participants with available biomedical data (at least a single viral load and CD4 count available at LTC (Baseline)); may differ for some variables based on missing data.
**
Includes youth linked to care only, youth who linked and went on to complete the other stages of the COC, and who had at least a single viral load and CD4 count available at LTC (Baseline).
***
Substances assessed included alcohol, barbiturates, club drugs, hallucinogens, inhalants, sedative hypnotics, amphetamines, cannabis, cocaine, heroin, methadone, other opiates and street hormones.